Cargando…

IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Almutairi, M., Bin Rsheed, M.A., Alharbi, J.T., Tourkmani, M.A., Alrasheedy, A.A, Alruthia, Y., Aljehani, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364884/ http://dx.doi.org/10.1016/j.diabres.2022.109334

Ejemplares similares

Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia
por: Faleh AlMutairi, Manal, et al.
Publicado: (2021)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

Prevalence of retinopathy and associated risk factors among high- and low-risk patients with type 2 diabetes mellitus: An observational study
por: Alghamdi, Salem A., et al.
Publicado: (2021)

IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19
por: Markova, T.N., et al.
Publicado: (2022)

IDF21-0678 Telemedicine Use and Selfmanagement Behaviors of Persons with Type 2 DM in Luzon Philippines during the COVID-19 Pandemic
por: Abaigar Jr., M., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

Utilizing diabetes registry for exploring sociodemographic and clinical characteristics of type II diabetic patients in Saudi Arabia
por: Tourkmani, Ayla M., et al.
Publicado: (2021)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

EHMTI-0295. Estimating prevalence and burden of major disorders of the brain in nepal: cultural, geographic, logistic and philosophical issues of methodology
por: Risal, A, et al.
Publicado: (2014)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis
por: Juangco, J.R., et al.
Publicado: (2022)

Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis
por: Alsugair, Hassan A., et al.
Publicado: (2021)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

Sociodemographic and clinical predictors of refractory type 2 diabetes patients: Findings from a case-control study
por: Alharbi, Turki J., et al.
Publicado: (2021)

The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus
por: Alharbi, Turki J., et al.
Publicado: (2018)

IDF21-0439 Type 2 Diabetes Mellitus History in the Prognosis of Hospitalized COVID-19 Patients – A Prospective Observational Study
por: Kochuparambil, J.J., et al.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

P02.95. Treating type 2 diabetes: a cross-sectional audit of naturopathic standards of care using the Naturopathic Patient Database
por: Habib, C, et al.
Publicado: (2012)

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry
por: Tourkmani, Ayla M., et al.
Publicado: (2022)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0294 Impact of COVID-19 pandemic lockdown in Spain on metabolic control of patients with type 2 diabetes mellitus
por: Cornadó-Cubells, G., et al.
Publicado: (2022)

IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination
por: Kanzy, A., et al.
Publicado: (2022)

IDF21-0510 Human Serum Metabolites as Potential Mediators from Obesity to COVID-19: A Network Mendelian Randomization Study
por: Huang, C., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

IDF21-0445 Telehealth utilization in Diabetes Centre during COVID Pandemic in South-Western Sydney: An evolving model of care
por: Manoharan, M., et al.
Publicado: (2022)

IDF21-0472 The effect of structured diabetes self-management education care on glycaemic control in Accra subsequent to COVID-19
por: Lamptey, R., et al.
Publicado: (2022)

IDF21-0542 Sharing “a.ma.dia” Experiences of how the Institution Have Faced COVID-19 Issues
por: Ramamonjisoa, H.A., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

Effects of liraglutide addition to multiple diabetes regimens on weight and risk of hypoglycemia for a cohort with type 2 diabetes followed in primary care clinics in Saudi Arabia
por: Albarkah, Yasser A., et al.
Publicado: (2019)

IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis
por: Shestakova, M., et al.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_77uh2lrcvscv7dkk56gkl219tn